URINE ADULTERANT CONTROLS - 2X 25ML BOTTLE
Bottle 1 Low Creatinine High pH, High Nitrite, Chromate, Bleach
Bottle 2 Low Creatinine, Low Specific Gravity, Low pH, Gluteraldehyde
URINE ADULTERANT CONTROLS - 2X 25ML BOTTLE Bottle 1 Low Creatinine High pH, High Nitrite, Chromate, Bleach Bottle 2 Low Creatinine, Low Specific Gravity, Low pH, Gluteraldehyde
The ONE-SCREEN 50 ml vial, Negative synthetic urine control, is specifically formulated for use with all hand held onsite drug screening devices. KEY ADVANTAGES Controls good for 24 months from date of manufacture if refrigerated Stable for up to 12 months at room temperature (77 F) Extended stability at refrigerated temperatures (35-46 F) Synthetic urine-based matrix simulates patient samples Stable at room temperature for a year after date of manufacture, 2 years if refrigerated Recommended by the majority of handheld device manufacturers Ready to use in 50 mL and call for customized 20 mL vial sizes The Detectabuse controls are designed to monitor and validate the performance of drugs of abuse detection methods at levels established by SAMHSA, CAP/AACC and many state programs. The Detectabuse control urine's are compatible with all quantitative and qualitative drug detection procedures which are sufficiently sensitive to detect the control constituents. They should be treated as any "unknown specimen while following the specific protocol of the assay being used.This product is intended to be used by health care professionals as an integral part of good laboratory practices.
INTENDED USE UrineCheck 7 is a fast dip-and-read test for the determination of diluted or adulterated urine specimens. It is an important pre-screening test for any drug-testing program. Each bottle contains 25 strips. SUMMARY AND EXPLANATION UrineCheck 7 drug adulteration tests are firm plastic strips to which seven different reagent areas are affixed. UrineCheck 7 test strips are ready-to-use and disposable. No equipment is required for its use. Only fresh and uncentrifuged urine samples without preservatives are to be used. UrineCheck 7 provides tests for Creatinine, Nitrite, pH, Specific Gravity, Glutaraldehyde, Oxidants, and Pyridium Chlorochromate in urine. Test results may be useful for assessing the integrity of the urine sample prior to Drugs-of-Abuse testing; for example, whether the sample is possibly diluted with water or other liquids as indicated by the creatinine and specific gravity tests. UrineCheck 7 detects whether the sample contains commercially available adulterants including nitrite, glutaraldehyde, bleach, pyridinium chlorochromate and other oxidizing agents. UrineCheck 7 can also assess whether the sample is possibly contaminated by acidic (vinegar) or basic (ammonia solution) adulterants as indicated by the pH test.
Our HCG Strips are a reliable and user-friendly solution for at-home pregnancy testing. These highly sensitive strips are designed to detect the presence of human chorionic gonadotropin (HCG) hormone in urine, a hormone produced during pregnancy. With their simple, dip-and-read design, these strips provide quick and accurate results within minutes. A clearly visible test and control line make interpretation effortless, even for first-time users. Our HCG Strips are manufactured with precision, ensuring consistent and dependable results. These strips offer privacy and convenience, empowering individuals to confirm pregnancy discreetly and with confidence in the comfort of their own homes.
INTENDED USE The HCG s/u Gold Rapid Screen Test(RST)is a chromatographic immunoassay for the early detection of human chronic gonadotropin (HCG) in serum/plasma or urine specimens. INTRODUCTION HCG is a glycoprotein hormone secreted by the developing placenta during pregnancy. The concentration of HCG in serum is approximately equal to the concentration in urine. The concentrations of HCG in urine and serum continue to rise during the first trimester of pregnancy to as high as 100,000 mIU/ml. HCG appears in urine shortly after conception, and continues to increase during the early stages of pregnancy, making it an excellent indicator for the detection of pregnancy. PRINCIPLE The membrane of the test device was coated with anti HCG antibodies on the test region and goat anti mouse IgG antibodies on the control region. During the test, urine specimen is allowed to react with the HCG monoclonal antibody-colloid gold conjugate, which was pre-dried on the test strip. The mixture then moves upward on the membrane chromatographically by capillary action. For a positive specimen, the conjugate binds to the HCG forming an antibody-antigen complex. This complex is captured by anti HCG antibody immobilized on the test region (T) and produces a pink color band when HCG concentration is equal to or greater than 25mIU/ml. Absence of this colored band in the test region suggests a negative result. To serve as a procedural control, a colored band at the control region(C) will always appear regardless the presence or absence of HCG. STORAGE
INTENDED USE The HCG s/u Gold Rapid Screen Test(RST)is a chromatographic immunoassay for the early detection of human chronic gonadotropin (HCG) in serum/plasma or urine specimens. INTRODUCTION HCG is a glycoprotein hormone secreted by the developing placenta during pregnancy. The concentration of HCG in serum is approximately equal to the concentration in urine. The concentrations of HCG in urine and serum continue to rise during the first trimester of pregnancy to as high as 100,000 mIU/ml. HCG appears in urine shortly after conception, and continues to increase during the early stages of pregnancy, making it an excellent indicator for the detection of pregnancy. PRINCIPLE The membrane of the test device was coated with anti HCG antibodies on the test region and goat anti mouse IgG antibodies on the control region. During the test, urine specimen is allowed to react with the HCG monoclonal antibody-colloid gold conjugate, which was pre-dried on the test strip. The mixture then moves upward on the membrane chromatographically by capillary action. For a positive specimen, the conjugate binds to the HCG forming an antibody-antigen complex. This complex is captured by anti HCG antibody immobilized on the test region (T) and produces a pink color band when HCG concentration is equal to or greater than 25mIU/ml. Absence of this colored band in the test region suggests a negative result. To serve as a procedural control, a colored band at the control region(C) will always appear regardless the presence or absence of HCG. STORAGE The kits should be stored at temperature 4-30°C� the sealed pouch for the duration of the shelf life (24months).
Products - Human Chorionic Gonadotropin (HCG) Test Midstream (Colloidal Gold Immunochromatographic Assay) Product Description - Sensitivity: 25 mIU/ml Accuracy: > 99.5% ISO13485 & CE approved INTENDED USE Easy-Sweet hCG Test Midstream is an in vitro diagnostic (IVD) qualitative test for rapid detection of hCG in urine. This test is designed for self-testing use only. PRINCIPLE Easy-Sweet. hCG Midstream is two-side sandwich immunoassay for the qualitative determination of human chorionic gonadotropin (hCG) in urine. The membrane was precoated with anti alpha hCG capture antibodies on the test band region and goat anti mouse on the control band region. During the test, the urine specimen is allowed to react with anti beta hCG monoclonal antibody-colloid gold conjugate, which was predried on the test Midstream. The mixture then moves forward on the membrane by the capillary action. For a positive specimen, the conjugate binds to the hCG forming an antibody-antigen complex. This complex is captured by anti alpha hCG antibody on the test region to produces a visual pink color band when hCG concentration in specimen is equal to or greater than 25 mIU/ml. Regardless of the presence of hCG, as the mixture continues to move across the membrane to the control band region, the complex is captured by immobilized goat anti mouse antibodies to form a distinct pink colored control band. The presence of the control band indicated: 1) a normal flow is obtained, 2) antibody pre-coated on control line and colloidal gold conjugate are functional. 1 pc/individual pouch , 500pcs/ctn or customized
AMP INTENDED USE The AMP Gold Rapid Screen Test is a qualitative competitive binding immunoassay for determination of Amphetamine in urine. AMP PRINCIPLE The Amp Gold Rapid Screen Test is a chromatographic absorbent device in which drug or drug metabolites in a sample compete with drug antigen immobilized on a porous membrane support for limited antibody sites. Labeled antibody-dye conjugate mixes with sample specimen and binds to the free drug presented in sample forming an antibody-antigen complex. This complex prevents the formation of pink color bands in the test zone immobilized antigen conjugate when the drug is presented in the sample urine above the detection levels (1000ng/ml for Amphetamine). Unbound dye conjugate binds to the reagent in the control zone and produces a pink-rose color band, demonstrating that the reagents and device are functioning correctly. A negative specimen produces two distinct color bands, one for the control in the �¢??C�¢?? zone and one for Amphetamine in the �¢??T�¢?? zone. AMP REAGENTS AND MATERIALS PROVIDED 1. Test Device A pouched cassette contains a single test for Amphetamine 2. Dropper A transfer pipette seal in foil pouch together with test device 3. Operating Instructio MATERIALS REQUIRED BUT NOT PROVIDED AMP MATERIALS REQUIRED BUT NOT PROVIDED Packaging Details: Pouch+Box+Carton packaging (1) With our companyâ??s Logo (2) With the natural package (3) With OEM package (4) ODM Anna Lee Int'l Market Executive
Home Menopause Test Strip is an in vitro diagnostic (IVD) qualitative test for rapid detection of human Follicle Stimulating Hormone (FSH) in urine at a sensitivity of 25mIU/ml. SUMMARY AND EXPLANATION OF THE TEST Follicle Stimulating Hormone (FSH) is a peptide hormone produced in the pituitary gland of the brain. It is normally present in the blood or urine varying in concentration with the stage of the menstrual cycle. When estrogen levels drop, FSH is released from the pituitary gland indicating that either a woman in mid-menstrual cycle or the onset of perimenopause. During early menopause, changes take place in the balance of hormones that regulate and control menstrual cycles. As a woman grows older and passes out of childbearing stage of life, the ovaries gradually make less of the hormone estrogen and FSH increases.FSH normally regulates the growth and development of an egg. Once this part of the monthly cycle is complete, FSH production is stopped and it returns to normal. As the body decreases estrogen production with age, more FSH is made. Over time these hormone changes cause menstrual periods to stop completely and "menopause" has occurred. The slow change in ovary function can happen between 2 and 10 years before the final period. This early stage before menopause is called perimenopause. During this stage, the levels of FSH may rise to positive levels and slowly return to normal, causing irregular or missed periods. The testing for FSH should be performed twice to help identify the levels of FSH throughout a menstrual cycle. PRECAUTION 1. For in vitro diagnostic use only. 2. Do not use after expiration date. 3. Test device should remain sealed until ready for use. Do not use if pouch is damaged or opened. 4. Read this instruction carefully before performing the test. 5. Do not re-use the test device. 6. Do not eat the desiccant in the pouch.
